Cargando…

Clinical outcomes of using plasma in COVID-19 convalescent critically ill patients

Detalles Bibliográficos
Autores principales:	Astola Hidalgo, I., Fernández Rodríguez, A., Martínez Revuelta, E., Martínez Revuelta, M., Ojea, A.M., Herrero Puente, P., Escudero Augusto, D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier España, S.L.U. and SEMICYUC. 2023
Materias:	Scientific Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9537249/ http://dx.doi.org/10.1016/j.medine.2022.10.002

Ejemplares similares

Resultados del uso de plasma de pacientes convalecientes de COVID-19 en pacientes críticos
por: Astola Hidalgo, I., et al.
Publicado: (2023)

Functional status of recovered critical COVID-19 patients: An assessment of a convalescent cohort
por: Sousa, L., et al.
Publicado: (2022)

Functional status of recovered critical COVID-19 patients: An assessment of a convalescent cohort
por: Sousa, L., et al.
Publicado: (2022)

Effects of vaccination against COVID-19 on the evolution of critically ill patients()
por: Morales Varas, G., et al.
Publicado: (2022)

Mepolizumab and COPD in Real Life
por: Revuelta-Salgado, Fernando, et al.
Publicado: (2021)

Hyperglycemia in Acute Critically Ill COVID-19 Patients
por: Cilloniz, Catia, et al.
Publicado: (2023)

Predictive biomarkers of mortality in critically ill patients with COVID-19()
por: Sirvent, J.M., et al.
Publicado: (2022)

D-dimer and right ventricular abnormalities as prognostic factors in critically ill COVID-19 patients
por: Gonzalez-Fernandez, Oscar, et al.
Publicado: (2020)

The midline venous catheter in critically ill COVID-19 patients
por: Blanco, P., et al.
Publicado: (2022)

The midline venous catheter in critically ill COVID-19 patients
por: Blanco, P., et al.
Publicado: (2022)

COVID-19 convalescent plasma transfusion
por: Langhi, Dante Mário, et al.
Publicado: (2020)

Rethinking the role of COVID-19 convalescent plasma in the critically ill
por: Casadevall, Arturo, et al.
Publicado: (2023)

Outcomes of Critically Ill Very Old Patients With Community-Acquired Pneumonia and Acute Respiratory Distress Syndrome
por: Cillóniz, Catia, et al.
Publicado: (2022)

Methadone as a rescue drug for difficult-to-sedate critically ill patients suffering from ARDS related to SARS-CoV-2 infection()
por: Fernández-Tobar, R., et al.
Publicado: (2022)

Myocardial injury as a prognostic factor in critically ill patients with severe SARS-Cov-2 pneumonia
por: Villavicencio, C., et al.
Publicado: (2023)

Myocardial injury as a prognostic factor in critically ill patients with severe SARS-Cov-2 pneumonia
por: Villavicencio, C., et al.
Publicado: (2023)

Anti-ACTH antibodies in critically ill Covid-19 patients: A potential immune evasion mechanism of SARS-CoV-2
por: Pérez-Torres, D., et al.
Publicado: (2022)

Anti-ACTH antibodies in critically ill Covid-19 patients: A potential immune evasion mechanism of SARS-CoV-2
por: Pérez-Torres, D., et al.
Publicado: (2022)

The Efficacy of Convalescent Plasma Use in Critically Ill COVID-19 Patients
por: Tirnea, Livius, et al.
Publicado: (2021)

Viral detection and serological response in critically ill patients with SARS-CoV-2. Implications for isolation withdrawal()
por: García Garmendia, J.L., et al.
Publicado: (2020)

Convalescent plasma treatment of critically ill intensive care COVID‐19 patients
por: Lindemann, Monika, et al.
Publicado: (2021)

Effect of Convalescent Plasma in Critically Ill Patients With COVID-19: An Observational Study
por: Kurtz, Pedro, et al.
Publicado: (2021)

A case of COVID-19 Convalescent Plasma Donation in Greece: Directed donation for compassionate use in the donor's critically ill father
por: Vlachogianni, Glykeria, et al.
Publicado: (2020)

Association of Chronic Critical Illness and COVID-19 in Patients Admitted to Intensive Care Units: A Prospective Cohort Study
por: Pérez-Anibal, Eduard, et al.
Publicado: (2023)

Post-COVID syndrome: Turning convalescence into illness?
por: Cozzi, Giorgio, et al.
Publicado: (2021)

Convalescent plasma for patients with COVID-19
por: Zeng, Furong, et al.
Publicado: (2020)

CONVALESCENT PLASMA THERAPY IN CRITICALLY ILL PATIENTS WITH LATE STAGE COVID-19
por: Kumar, Neil, et al.
Publicado: (2020)

High flow oxygen therapy in the treatment of SARS-CoV-2 pneumonia()
por: González-Castro, A., et al.
Publicado: (2022)

Mechanical power greater than 17 joules/min in patients with respiratory failure secondary to SARS-CoV-2 infection
por: González-Castro, A., et al.
Publicado: (2023)

What's new in critical illness and injury science? Convalescent plasma for coronavirus disease-2019 patients with severe or critical illness
por: Miller, Andrew Carl, et al.
Publicado: (2021)

First and second wave of coronavirus-19 disease: A comparative study in patients hospitalized in an ICU of a third-level university hospital()
por: González-Castro, A., et al.
Publicado: (2022)

Combined therapy of tocilizumab and corticosteroids in severe SARS-CoV-2 disease()
por: González-Castro, A., et al.
Publicado: (2022)

Echocardiographic findings in critical patients with COVID-19
por: Rodríguez-Santamarta, Miguel, et al.
Publicado: (2020)

Convalescent Plasma Therapy in Critically Ill COVID-19 Patients: An Open Label Trial
por: Khamis, Faryal, et al.
Publicado: (2021)

Convalescent plasma for COVID-19 considerations
por: Adiwinata Pawitan, Jeanne
Publicado: (2021)

Convalescent Plasma for Preventing Critical Illness in COVID-19: a Phase 2 Trial and Immune Profile
por: Sturek, Jeffrey M., et al.
Publicado: (2022)

Convalescent plasma in the management of COVID-19 pneumonia
por: Elbadawi, Ayman, et al.
Publicado: (2021)

In Reply—How Safe Is COVID-19 Convalescent Plasma?
por: Joyner, Michael J., et al.
Publicado: (2021)

Elucidating the pivotal role of convalescent plasma therapy in critically ill COVID-19 patients: A review
por: Richard, Seidu A., et al.
Publicado: (2020)

Prone positioning and convalescent plasma therapy in a critically ill pregnant woman with COVID‐19
por: Donzelli, Massimo, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_6c9h2s455ovaqrqo2gi6m1mjve